3c453d2fd65f762b10ef335231254513148cb6f273da6499d0d86a02a9d32fdc

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

9696f8fb87efeb8b7dae33a6d4a56dc3ae987de2e0a540662befa3dc8c215f3b

fbda71cec35937328c272731db5fdaaffa1374cc1cb0449d5b5d80f9200b48a8

23108f286aca1266a43303ff746575c53687e8c58746cd61e884e8393f7a5bdc

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable, Net (USD, thousands)

Inventory (USD, thousands)

Other Current Assets (USD, thousands)

Assets Held for Sale (USD, thousands)

Total Current Assets (USD, thousands)

Investment in Equity Securities (USD, thousands)

Property, Plant and Equipment, Net (USD, thousands)

Intangibles, Net (USD, thousands)

Goodwill (USD, thousands)

Deferred Tax Assets, Net (USD, thousands)

Other Long-Term Assets (USD, thousands)

Total Assets (USD, thousands)

Current Portion of Long-Term Debt and Other Borrowings (USD, thousands)

Accounts Payable (USD, thousands)

Accrued Expenses and Other Liabilities (USD, thousands)

Total Current Liabilities (USD, thousands)

Asset Retirement Obligations (USD, thousands)

Long-Term Debt, Net and Other Borrowings (USD, thousands)

Other Long-Term Liabilities (USD, thousands)

Total Liabilities (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

Treasury Stock at Cost (USD, thousands)

Retained Earnings (USD, thousands)

Accumulated Other Comprehensive Loss (USD, thousands)

Total Stockholders’ Equity (USD, thousands)

Total Liabilities and Stockholders’ Equity (USD, thousands)

931f81e5da9e2a79c0e72a5a70b0ad32308c5dbca6890d80c2b90a27ad27b374

Radiopharmaceutical Oncology

- PYLARIFY

- Other Radiopharmaceutical Oncology

Precision Diagnostics

- DEFINITY

- TechneLite

- Other Precision Diagnostics

Strategic Partnerships and Other Revenue

Total Revenue

25865e6307517d156d2a72c9d7f213185f102c54235def87be16c5db5669fa33

Lantheus Holdings Inc (LNTH)

Financials